Related references
Note: Only part of the references are listed.Vitamin D and Stage 5 Chronic Kidney Disease: A New Paradigm?
James Goya Heaf et al.
SEMINARS IN DIALYSIS (2012)
Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients
Victoria A. Kumar et al.
JOURNAL OF NEPHROLOGY (2011)
Serum 25(OH)-Cholecalciferol Concentration Is Associated with Hemoglobin Level and Erythropoietin Resistance in Patients on Maintenance Hemodialysis
Z. Kiss et al.
NEPHRON CLINICAL PRACTICE (2011)
Vitamin D deficiency and anemia: a cross-sectional study
John J. Sim et al.
ANNALS OF HEMATOLOGY (2010)
Vitamin D deficiency and anemia in early chronic kidney disease
Neha M. Patel et al.
KIDNEY INTERNATIONAL (2010)
Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium
Pornpimol Rianthavorn et al.
PEDIATRIC NEPHROLOGY (2010)
25-Hydroxyvitamin D Deficiency and Inflammation and Their Association with Hemoglobin Levels in Chronic Kidney Disease
Jessica Kendrick et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Vitamin D Insufficiency and Deficiency in Children with Early Chronic Kidney Disease
Wacharee Seeherunvong et al.
JOURNAL OF PEDIATRICS (2009)
A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease
Vladimir Belostotsky et al.
PEDIATRIC NEPHROLOGY (2009)
Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease
Shina Menon et al.
PEDIATRIC NEPHROLOGY (2008)
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets
Steven Fishbane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Vitamin D levels and early mortality among incident hemodialysis patients
M. Wolf et al.
KIDNEY INTERNATIONAL (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients
Georges Saab et al.
NEPHRON CLINICAL PRACTICE (2007)
25-hydroxyvitamin D3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds
D Somjen et al.
CIRCULATION (2005)
25-hydroxyvitamin D-3 1 alpha-hydroxylase expression in breast cancer and use of non-1 alpha-hydroxylated vitamin D analogue
U Segersten et al.
BREAST CANCER RESEARCH (2005)
Hyperparathyroidism and anemia in uremic subjects: A combined therapeutic approach
D Brancaccio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Vitamin D2 is much less effective than vitamin D3 in humans
LAG Armas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Novel role of 1,25(OH)2D3 in induction of erythroid progenitor cell proliferation
D Ben Alon et al.
EXPERIMENTAL HEMATOLOGY (2002)
Share Paper
